Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis

被引:0
|
作者
Pham, Hoang Nam [1 ]
Pham, Linh [2 ]
Sato, Keisaku [3 ]
机构
[1] Vietnam Acad Sci & Technol, Univ Sci & Technol Hanoi, Dept Life Sci, Hanoi, Vietnam
[2] Texas A&M Univ, Dept Sci & Math, Cent Texas, Killeen, TX USA
[3] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
关键词
deconvolution analysis; CIBERSORTx; primary sclerosing cholangitis; primary biliary cholangitis; hepatic cell landscape; PLASMA-CELLS; CHOLANGIOCYTES; ACTIVATION; EXPRESSION; DAMAGE;
D O I
10.3389/fmed.2024.1327973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are characterized by ductular reaction, hepatic inflammation, and liver fibrosis. Hepatic cells are heterogeneous, and functional roles of different hepatic cell phenotypes are still not defined in the pathophysiology of cholangiopathies. Cell deconvolution analysis estimates cell fractions of different cell phenotypes in bulk transcriptome data, and CIBERSORTx is a powerful deconvolution method to estimate cell composition in microarray data. CIBERSORTx performs estimation based on the reference file, which is referred to as signature matrix, and allows users to create custom signature matrix to identify specific phenotypes. In the current study, we created two custom signature matrices using two single cell RNA sequencing data of hepatic cells and performed deconvolution for bulk microarray data of liver tissues including PSC and PBC patients.Methods Custom signature matrix files were created using single-cell RNA sequencing data downloaded from GSE185477 and GSE115469. Custom signature matrices were validated for their deconvolution performance using validation data sets. Cell composition of each hepatic cell phenotype in the liver, which was identified in custom signature matrices, was calculated by CIBERSORTx and bulk RNA sequencing data of GSE159676. Deconvolution results were validated by analyzing marker expression for the cell phenotype in GSE159676 data.Results CIBERSORTx and custom signature matrices showed comprehensive performance in estimation of population of various hepatic cell phenotypes. We identified increased population of large cholangiocytes in PSC and PBC livers, which is in agreement with previous studies referred to as ductular reaction, supporting the effectiveness and reliability of deconvolution analysis in this study. Interestingly, we identified decreased population of small cholangiocytes, periportal hepatocytes, and interzonal hepatocytes in PSC and PBC liver tissues compared to healthy livers.Discussion Although further studies are required to elucidate the roles of these hepatic cell phenotypes in cholestatic liver injury, our approach provides important implications that cell functions may differ depending on phenotypes, even in the same cell type during liver injury. Deconvolution analysis using CIBERSORTx could provide a novel approach for studies of specific hepatic cell phenotypes in liver diseases.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Primary sclerosing cholangitis
    Stephen A. Mitchell
    Roger W. Chapman
    Clinical Reviews in Allergy & Immunology, 2000, 18 : 185 - 214
  • [42] Recall processes for biliary cytology in primary sclerosing cholangitis
    Eaton, John E.
    Gossard, Andrea A.
    Talwalkar, Jayant A.
    CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (03) : 287 - 294
  • [43] Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis
    Fleming, KA
    Boberg, KM
    Glaumann, H
    Bergquist, A
    Smith, D
    Clausen, OPF
    JOURNAL OF HEPATOLOGY, 2001, 34 (03) : 360 - 365
  • [44] A Patient with Primary Sclerosing Cholangitis and Diffuse Biliary Dilation
    Fejleh, M. Phillip
    Yang, Sung-Eun
    Kim, Stephen
    GASTROENTEROLOGY, 2021, 160 (03) : E17 - E18
  • [45] Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis
    Greverath, Lena Maria
    Leicht, Elise
    de Chamorro, Nina Wald
    Wilde, Anne-Christin Beatrice
    Steinhagen, Lara Marleen
    Lieb, Charlotte
    Schmelzle, Moritz
    Chopra, Sascha
    Shibolet, Oren
    Fischer, Janett
    Berg, Thomas
    Tack, Frank
    Mueller, Tobias
    HEPATOLOGY RESEARCH, 2020, 50 (03) : 321 - 329
  • [46] Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome
    Jing, Miaoyu
    Zhang, Wenjia
    Xia, Min
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (12) : 765 - +
  • [47] Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
    Jopson, Laura
    Dyson, Jessica K.
    Jones, David E. J.
    CLINICS IN LIVER DISEASE, 2016, 20 (01) : 131 - +
  • [48] Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis
    Washington, K
    Clavien, PA
    Killenberg, P
    HUMAN PATHOLOGY, 1997, 28 (07) : 791 - 795
  • [49] Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis
    Zein C.O.
    Lindor K.D.
    Current Gastroenterology Reports, 2010, 12 (1) : 13 - 22
  • [50] Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
    Boonstra, Kirsten
    Beuers, Ulrich
    Ponsioen, Cyriel Y.
    JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1181 - 1188